Uganda on Thursday received an assortment of 1,200 Ebola trial vaccines from the World Health Organization which will be used in clinical trials, according to Ministry officials.
This is Uganda’s first batch of one of the three candidate vaccines against the Sudan Ebola virus which broke out in the country in September.
The Minister of Health Dr. Jane Ruth Aceng said that the 1,200 doses had arrived from the US-based Sabin Vaccine Institute and more were on the way.
“Today we are happy that we have the first batch, we shall be receiving other doses from Merck and from Oxford,” she said.
The WHO will send two more vaccine candidates to Uganda — the first jointly produced by the University of Oxford and Serum Institute of India, and the second by Merck & Co Inc.
There are currently no licensed vaccines for the Sudan strain of Ebola that is causing the deadly infection in Uganda and the trial is to determine whether any or all of the three are effective in combating the strain.
Acheng is expected to announce the start date of trials soon.
Health officials have previously said everything was in place for the trials to start and they were only waiting for the doses to arrive.
Uganda has been actively trying to contain the highly infectious Ebola since the outbreak was declared in September.
According to the Health Ministry, there are currently no new Ebola cases. The country is counting down toward 42 straight days without any new Ebola cases reported. When that period ends on Jan. 10, it will be declared Ebola-free.
So far, 56 deaths have been reported in the East African nation due to Ebola.

